|
Small molecules
guide immunity
Take advantage of EMC's
experience in the design of optimised lipopeptide
conjugates for your applications in vaccine development,
antibody production, CTL priming and in basic
research of immunomodulation, e.g. innate and
acquired immunity. more...
Compounds for Toll-like
receptor research
Lipopeptides, e.g. Pam3Cys-SKKKK, were described
in 1999 by
Aliprantis et al. as synthetic activators of Toll-like
receptor 2.
Now available: New issue of our
EMC Biochemicals Catalogue 2012
The brochure contains e.g. analogues of Pam3Cys-SKKKK,
of Pam2Cys-SKKKK,
and of FSL-1 and corresponding biotinylated or
fluorescently labelled conjugates.
View some example structures. more... |
